Economic aspects of hospital treated pneumococcal pneumonia and the results of Pneumo 23 vaccine use in Serbia
INTRODUCTION In Serbia, there is a significant number of persons suffering of pneumococcal pneumonia. Persons aged 65 years or older, immunocompromised patients, patients with co-morbidities, such as chronic obstructive lung disease and congestive heart failure, are at the highest risk for developin...
Main Authors: | Adžić Tatjana, Rosić Ilija, Jovanović Dragana, Medić-Stojanac Snežana |
---|---|
Format: | Article |
Language: | English |
Published: |
Serbian Medical Society
2008-01-01
|
Series: | Srpski Arhiv za Celokupno Lekarstvo |
Subjects: | |
Online Access: | http://www.doiserbia.nb.rs/img/doi/0370-8179/2008/0370-81790812625A.pdf |
Similar Items
-
Eventos adversos após vacinação contra o pneumococo Adverse events after pneumococcal vaccination
by: Maria Rita Donalisio, et al.
Published: (2007-02-01) -
STREPTOCOCCUS PNEUMONIAE SEROTYPE DISTRIBUTION AFTER THE INTRODUCTION OF PNEUMOCOCCAL CONJUGATE VACCINES
by: Mariya Malcheva
Published: (2019-06-01) -
Impact of pneumococcal conjugate vaccines on hospitalizations for pneumonia in the United States
by: Andrew D. Wiese, et al.
Published: (2019-04-01) -
Association between nasopharyngeal colonization with multiple pneumococcal serotypes and total pneumococcal colonization density in young Peruvian children
by: Leigh M. Howard, et al.
Published: (2023-09-01) -
Pneumococcal Meningitis in Children: Evaluation of 46 Cases
by: Ayper SOMER, et al.
Published: (1999-06-01)